Induction of exocytosis from permeabilized mast cells by the guanosine triphosphatases Rac and Cdc42.
We applied recombinant forms of the Rho-related small guanosine triphosphatases (GTPases) Rac2 and Cdc42/G25K to permeabilized mast cells to test their ability to regulate exocytotic secretion. Mast cells permeabilized with streptolysin-O leak soluble (cytosol) proteins over a period of 5 min and become refractory to stimulation by Ca2+ and guanosine triphosphate (GTP)gammaS over about 20-30 min. This loss of sensitivity is likely to be due to loss of key regulatory proteins that are normally tethered at intracellular locations. Exogenous proteins that retard this loss of sensitivity to stimulation may be similar, if not identical, to those secretory regulators that are lost. Recombinant Rac and Cdc42/G25K, preactivated by binding GTPgammaS, retard the loss of sensitivity (run-down) and, more importantly, enable secretion to be stimulated by Ca2+ alone. Investigation of the concentration dependence of each of these two GTPases applied individually to the permeabilized cells, and of Cdc42/G25K applied in the presence of an optimal concentration of Rac2, has provided evidence for a shared effector pathway and also a second effector pathway activated by Cdc42/G25K alone. Dominant negative mutant (N17) forms of Rac2 and Cdc42/G25K inhibit secretion induced by Ca2+ and GTPgammaS. Our data suggest that Rac2 and Cdc42 should be considered as candidates for GE, GTPases that mediate exocytosis in cells of hematopoeitic origin.
Brown
A M
AM
Department of Physiology, University College, London WC1E 6BT, United Kingdom.
O'Sullivan
A J
AJ
Gomperts
B D
BD
D001426:Bacterial Proteins; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology; D018797:Cell Cycle Proteins / Q000502:physiology*; D002463:Cell Membrane Permeability; D005089:Exocytosis / Q000187:drug effects / Q000502:physiology*; D020558:GTP Phosphohydrolases / Q000494:pharmacology / Q000502:physiology*; D019204:GTP-Binding Proteins / Q000378:metabolism / Q000502:physiology*; D020730:Guanine Nucleotide Dissociation Inhibitors; D016244:Guanosine 5'-O-(3-Thiotriphosphate) / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D008407:Mast Cells / Q000187:drug effects / Q000378:metabolism*; D011993:Recombinant Fusion Proteins / Q000494:pharmacology / Q000502:physiology; D013301:Streptolysins / Q000494:pharmacology; D020764:cdc42 GTP-Binding Protein; D020744:rac GTP-Binding Proteins; D062947:rho-Specific Guanine Nucleotide Dissociation Inhibitors
D001426:Bacterial Proteins; D018797:Cell Cycle Proteins; D020730:Guanine Nucleotide Dissociation Inhibitors; D011993:Recombinant Fusion Proteins; D013301:Streptolysins; D062947:rho-Specific Guanine Nucleotide Dissociation Inhibitors; C025964:streptolysin O; D016244:Guanosine 5'-O-(3-Thiotriphosphate); D020558:GTP Phosphohydrolases; D019204:GTP-Binding Proteins; D020764:cdc42 GTP-Binding Protein; D020744:rac GTP-Binding Proteins; D002118:Calcium